-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Tenaya Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
- Tenaya Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$26.7M, a 13.6% increase year-over-year.
- Tenaya Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$123M, a 8.6% increase year-over-year.
- Tenaya Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$131M, a 4.44% decline from 2022.
- Tenaya Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$126M, a 72.5% decline from 2021.
- Tenaya Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$72.8M, a 87.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)